Lv6
1810 积分 2022-01-04 加入
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C
2个月前
已完结
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors
7个月前
已完结
CD146, a therapeutic target involved in cell plasticity
8个月前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
8个月前
已完结
Antibody-drug conjugates for targeted cancer therapy: recent advances in potential payloads
9个月前
已完结
Overcoming multidrug resistance in gastrointestinal cancers with a CDH17-targeted ADC conjugated to a DNA topoisomerase inhibitor
10个月前
已完结
皖公网安备34019202002308
